TANDEM DIABETES CARE INC (TNDM) insider trading

By person

17 insiders · 1 transaction

3.8×

John Sheridan holds only 3.8 times base salary in stock. $3.07M of shares against $790.58K in salary for 2025.

Salary from the company's own proxy. The shares are what John Sheridan last reported holding, valued at $19.15, the price Common Stock was last bought or sold at on the open market here, on 27 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Christopher J Twomey

Director

—

$32.56K (1) scheduled

−$32.56K

37,114

0.0533%

$710.73K

+54.8%

Kim D Blickenstaff

Director

—

165,190

0.2374%

$3.16M

−19.5%

John F Sheridan

President & CEO

—

160,260

0.2303%

$3.07M

+222.0%

Leigh Vosseller

EVP & Chief Financial Officer

—

77,620

0.1116%

$1.49M

+142.1%

Susan Morrison

EVP & Chief Admin. Officer

—

52,788

0.0759%

$1.01M

+125.9%

Mark David Novara

EVP & Chief Commercial Officer

—

40,317

0.0579%

$772.07K

—

Elizabeth Anne Gasser

EVP, Chief Strategy Officer

—

34,505

0.0496%

$660.77K

+162.9%

Rick Carpenter

EVP & Chief Technology Officer

—

32,148

0.0462%

$615.63K

+151.1%

Jean-Claude Kyrillos

EVP & Chief Operating Officer

—

32,001

0.0460%

$612.82K

—

Shannon Marie Hansen

EVP & Chief Legal Officer

—

31,650

0.0455%

$606.10K

+227.0%

Peyton R Howell

Director

—

29,836

0.0429%

$571.36K

+78.8%

Dick Allen

Chair Emeritus

—

28,146

0.0405%

$539.00K

+75.9%

Kathleen McGroddy-Goetz

Director

—

26,612

0.0382%

$509.62K

+97.6%

Rajwant Sodhi

Director

—

24,280

0.0349%

$464.96K

+118.1%

Rebecca B Robertson

Director

—

22,542

0.0324%

$431.68K

+139.9%

Joao Paulo Falcao Malagueira

Director

—

22,458

0.0323%

$430.07K

+196.9%

Myoungil Cha

Director

—

22,458

0.0323%

$430.07K

+196.9%

TANDEM DIABETES CARE INC

What the insiders did Scheduled selling only

By person